Press release
Europe Platelet Rich Plasma Market to Reach US$ 87.2 Million in 2022
Platelet rich plasma (PRP) is a blood plasma product that contains elevated level of platelets and growth factors (at least four to ten times) than normal blood concentration. PRP is also called as also called platelet enriched plasma and platelet gel. While mostly derived from patient’s own blood, platelet rich plasma is widely used in the treatment of diseases such as orthopedic diseases, neurological diseases, and other minor injuries that require outpatient surgeries. Rising incidence of diseases such as orthopedic diseases, sports injuries, cardiovascular diseases, obesity, and neurological diseases and introduction of various devices for PRP preparation are the key factors that are likely to drive market growth. In addition, growing awareness about PRP therapy and its advantages, and aging population more prone to injuries and surgeries are the other factors that boost market growth. However, high cost of the devices and therapy and threat of treatment failures are some of the factors restricting the market growth to some extent.The autologous PRP segment dominated the PRP market in Europe in 2013. The dominance of this market segment was due to increasing demand for allogenic platelet rich plasma products. Thus, the allogenic segment is estimated to grow at the highest growth rate during the forecast period from 2014 to 2022. The growth of this market segment was majorly due to reduced wound healing time and high concentration of growth factors containing platelet rich plasma products. In case of a patient diagnosed with one of the blood disorders (leukemia, hemocytopenia, etc) with less number of platelets in the blood and without any significant clinical action, where allogenic PRP treatment would be recommended.
Browse Market Research Report @
http://www.transparencymarketresearch.com/europe-platelet-rich-plasma-market.html
Orthopedic was the largest application segment in 2013, accounting for 38.3% share of the PRP market in Europe. Large number of orthopedic and sports injuries and rise in geriatric population are the major factors driving the growth of this application segment. PRP products are widely used in cosmetic surgeries to enhance the rate of injury healing, improve facial aesthetics, and facelift treatments. In addition, cost-effectiveness and multiple applications of PRP in cosmetic surgeries are the major factors accelerating the growth of this segment. Therefore, these factors collectively propel the growth of cosmetic surgery application segment and it is estimated to grow at a highest rate during the forecast period from 2014 to 2022.
Geographically, the Europe platelet rich plasma market has been segmented as U.K., Germany, Italy, France, Spain and Rest of Europe. In 2013, U.K. dominated the Europe PRP market primarily due to increasing prevalence of orthopedic and reconstructive procedures and growing number of bariatric surgeries. Thus, PRP therapy is gaining wider acceptability as it provides effective treatment and faster recovery. For instance, tennis elbow affects around 300,000 people in the U.K. every year, where PRP is the most preferred treatment option. Moreover, growing preference for PRP therapy for sports injuries would boost market growth in the U.K.
The Europe PRP market is highly fragmented with the presence of a large number of small and large multinational players. Companies such as Arthrex, Inc., Biomet, Inc., and EmCyte Corporation dominated the Europe PRP market in 2013. Other minor players present in the Europe PRP market include AdiStem Ltd., Glofinn Oy, Medira Ltd., and Regen Lab SA.
Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4761
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe Platelet Rich Plasma Market to Reach US$ 87.2 Million in 2022 here
News-ID: 455312 • Views: …
More Releases from TMR - Healthcare

Clinical Trial Management System (CTMS) Market : Projection of Each Major Segmen …
With companies long having realized that the best way to remain competitive in the pharmaceutical industry is by ploughing back of profits into R&D projects, the demand for clinical trial management systems is expected to see an uptick. While this will help impel the market greatly in the coming years, what also needs to be taken into consideration that the cost of implementing such a system may deter investment decisions.
The…
Electronic Health Records Market : Industry Analysis and Detailed Profiles of to …
The global market for electronic health record (EHR) features a largely fragmented vendor landscape, with the presence of a large number of small and large players and the top five companies cumulatively accounting for a nearly 44% of the overall market in 2016. Leading vendors in the global EHR market are adopting inorganic growth strategies such as mergers and acquisitions to expand their reach across high-growth potential regional markets, consolidate…

Fuel Oil Market Intelligence Report Offers Growth Prospects
The global transportation industry has been growing at a significant pace since the past decade. Companies operating in the transportation industry are the largest consumers of the fuel oil. Apart from this, fuel oil also finds application in the petrochemical industry and petroleum refineries. The building materials industry is also on the rise since many years. The demand for fuel oil is expected to increase from the building materials industry.…

Thermoset Resin Market Global Industry Analysis, Trends and Forecast, 2016 - 202 …
The global composite industry has been expanding significantly in terms of production, technological advancements, and developments. Thermoset resin plays a vital role in the composite industry. Thermoset resins are used extensively in the manufacture of composites; these resins are employed in the fabrication of products for end-use industries such as aerospace, automotive, sporting goods, construction, electronics, and wind energy. The thermoset resin market can be segmented into six resin types:…
More Releases for PRP
Therapeutic PRP Tubes Market to Witness Growth at a 6.6% CAGR by 2031 | Regen La …
QYResearch A newly published report titled "Global Therapeutic PRP Tubes Market 2025 is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Therapeutic PRP Tubes market. For instance, the market dynamics section digs deep into the…
Global PRP Centrifuges Market Research Report 2023-2029
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Global PRP Centrifuges Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2018-2022) and forecast calculations (2023-2029), this report provides a comprehensive analysis of the global PRP Centrifuges market, including market size, share, demand, industry development status, and forecasts for the next few years. Provides advanced statistics…
Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth.
The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence…
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023"
The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million…
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its…
Platelet Rich Plasma (PRP) Market Forecast 2017-2021
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials.…